Prospective Sinonasal Cancer Multi-institution Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age30-99
SponsorMayo Clinic

About this trial

This is a multi-institution prospective study of patients with sinonasal malignancies. The goal of this study is to learn more about the course of sinonasal cancer, treatment outcomes, and patient quality of life. In addition, central mutational and genomic analysis of tumor tissue will be evaluated.

Eligibility criteria

Qualifiers

Subjects between the ages of 30 days (non-inclusive) and 99 years (inclusive)

Patients with a diagnosis of sinonasal cancer

Patients undergoing treatment at Mayo Clinic

Disqualifiers

Healthy individuals

Unwilling to sign the informed consent

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

1
Mayo Clinic in Rochester55905, RochesterMinnesota, United States

Sponsors and collaborators

Mayo Clinic

Lead sponsor